IDH1 and cancer: Our results on the interaction of TCA cycle-related metabolites with isolated KDM5B reveal the potential for its inhibition by some, but not all, of the tested compounds, including D-2HG, levels of which are elevated in cancer cells due to mutations to IDH1/2 [46].